Anti-TAGLN2 Antibody
Highest antigen sequence identity to the following orthologs:
Mouse ENSMUSG00000026547 (95%)
Rat ENSRNOG00000008301 (95%)
Recommended conditions:
Dilution: 1:200 - 1:500
Retrieval method: HIER pH6
Recommended conditions:
Working concentration: 0.4 µg/ml
Recommended conditions:
Fixation/Permeabilization: PFA/Triton X-100
Working concentration: 1-4 µg/ml
Validated in Western blot using relevant lysates (see Western blot application images above)
This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.
All characterization data for ENSG00000158710 on the Human Protein Atlas
Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy.
J Proteomics , 2012 Apr 3; 75(7):2236-51. Epub 2012 Feb 15
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
Br J Cancer , 2011 Mar 1; 104(5):808-818. Epub 2011 Feb 8
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
Oncotarget , 2011 Jan-Feb; 2(1-2):29-42. Epub 2011 Jan 25
Did we miss your publication?
Have you published using HPA001925? Please let us know and we will be happy to include your reference on this page.
Join the Explorer Program
Are you using our products in an application or species we have not yet tested? Why not articipate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 50% of the product price as a refund, or 50% discount on your next vial purchase.
Questions?
Our customer support and expert scientific support teams are here to help you succeed in your research.